Showing 41-50 of 2890 results for "".
Ocrevus Treatment in Pregnant and Lactating Women with Multiple Sclerosis
https://practicalneurology.com/programs/practical-neurology/ocrevus-treatment-pregnant-lactating-women-with-multiple-sclerosis/35558/Riley Bove, MD, UCSF School of Medicine, San Francisco, CA details results from the MINORE and SOPRANINO studies examining Ocrevus treatment in pregnant and lactating women with multiple sclerosis.Factors Influencing the Selection of Amyloid PET Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-amyloid-pet-tests-for-alzheimer-disease/37135/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of amyloid PET tests for Alzheimer disease.Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders
https://practicalneurology.com/programs/practical-neurology/narcolepsy-idiopathic-hypersomnia-and-general-sleep-disorders/30083/In this episode, Rajkumar Dasgupta, MD, Clinical Associate Professor at Keck School of Medicine of USC and sleep specialist, provides an in-depth review of what's new in sleep disorders, with a special focus on updates in narcolepsy and idiopathic hypersomnia.Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-dementia-and-psychosis-in-individuals-with-parkinson-disease/39935/Jorge Patino, MD, Movement Disorders Fellow, University of Cincinnati, Cincinnati, OH, provides an overview of dementia and psychosis in people with Parkinson disease, including clinical approaches for the diagnosis of these conditions, and nonpharmacologic, environmental, and pharmacologic treatmenHow to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
https://practicalneurology.com/videos/neurology-in-motion/how-to-communicate-the-results-of-alzheimer-disease-biomarker-tests-with-patients/39733/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses how to communicate the results of Alzheimer disease biomarker tests with patients.Factors Influencing the Selection of Blood Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-blood-tests-for-alzheimer-disease/39224/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of blood tests for Alzheimer disease.Cerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations
https://practicalneurology.com/diseases-diagnoses/stroke/cerebrovascular-inflammatory-conditions-diagnostic-challenges-and-treatment-considerations/36478/Abbas Kharal, MD, MPH, Neurologist at Cleveland Clinic Neurological Institute, Cleveland, OH, provides a review of cerebrovascular inflammatory conditions, with an emphasis on diagnostic challenges, the evolving treatment landscape, and the use of imaging and clinical responses to assist cliniciansSeeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin TherapeuticsNeurology Q&A: What Neurologists Should Know About Headache Patients and Complimentary Medicine
https://practicalneurology.com/diseases-diagnoses/headache-pain/neurology-qa-what-neurologists-should-know-about-headache-patients-and-complimentary-medicine/30804/Those who suffer from headaches may be more likely to use CAM than others are. Here's what research shows.A Q&A with Rebecca E. Wells, MD, MPH- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn-0707-dementia-pdf/31141/In the realm of dementia care, accurate CPT (Current Procedural Terminology) coding is crucial for appropriate reimbursement and reflecting the complexity of patient management. David S. Geldmacher, MD, addresses the challenges neurologists face when utilizing CPT codes for dementia evaluations in h